Stonegate Capital Partners Updates Coverage On GoHealth Inc. (GOCO) 2025 Q2
GoHealth Inc. (NASDAQ: GOCO) reported challenging Q2 2025 results, with net revenues declining 11.2% year-over-year to $94.0M. The company experienced significant decreases in partner revenue (-44.4%) and non-agency revenue (-79.4%), partially offset by growth in GoHealth Protect segment.
The company secured $115M in new and rolled-up loans and amended its credit agreement to waive near-term principal payments. Q2 resulted in a $115.9M net loss, including a $53M intangible asset impairment charge, though adjusted EBITDA showed slight improvement to -$11.3M year-over-year. Cost efficiency improved with marketing and consumer care expenses declining 26% and 33% respectively.
GoHealth Inc. (NASDAQ: GOCO) ha riportato risultati difficili nel secondo trimestre del 2025, con ricavi netti in calo dell'11,2% su base annua a 94,0 milioni di dollari. L'azienda ha registrato significative diminuzioni nei ricavi da partner (-44,4%) e nei ricavi non da agenzia (-79,4%), parzialmente compensate dalla crescita del segmento GoHealth Protect.
La società ha ottenuto 115 milioni di dollari in nuovi prestiti e rifinanziamenti e ha modificato il proprio accordo di credito per sospendere i pagamenti principali a breve termine. Il secondo trimestre si è chiuso con una perdita netta di 115,9 milioni di dollari, inclusa una svalutazione di attività immateriali di 53 milioni di dollari, anche se l'EBITDA rettificato ha mostrato un leggero miglioramento, attestandosi a -11,3 milioni di dollari su base annua. L'efficienza dei costi è migliorata con una riduzione delle spese di marketing e assistenza ai consumatori rispettivamente del 26% e 33%.
GoHealth Inc. (NASDAQ: GOCO) reportó resultados desafiantes en el segundo trimestre de 2025, con ingresos netos que disminuyeron un 11,2% interanual hasta 94,0 millones de dólares. La compañía experimentó caídas significativas en los ingresos de socios (-44,4%) y en los ingresos no relacionados con agencias (-79,4%), parcialmente compensadas por el crecimiento en el segmento GoHealth Protect.
La empresa aseguró 115 millones de dólares en nuevos préstamos y refinanciamientos y modificó su acuerdo de crédito para eximir los pagos principales a corto plazo. El segundo trimestre terminó con una pérdida neta de 115,9 millones de dólares, incluyendo un cargo por deterioro de activos intangibles de 53 millones, aunque el EBITDA ajustado mostró una ligera mejora hasta -11,3 millones año tras año. La eficiencia en costos mejoró con una reducción del 26% en gastos de marketing y del 33% en atención al consumidor.
GoHealth Inc. (NASDAQ: GOCO)는 2025년 2분기에 어려운 실적을 보고했으며, 순매출은 전년 대비 11.2% 감소한 9,400만 달러를 기록했습니다. 회사는 파트너 매출이 44.4% 감소하고 비대행 매출이 79.4% 감소하는 등 큰 폭의 하락을 겪었으나, GoHealth Protect 부문의 성장이 일부 상쇄했습니다.
회사는 1억 1,500만 달러의 신규 및 재융자 대출을 확보하고 단기 원금 상환을 면제하는 신용 계약을 개정했습니다. 2분기 순손실은 1억 1,590만 달러였으며, 이 중 5,300만 달러의 무형자산 손상차손이 포함되어 있습니다. 다만 조정 EBITDA는 전년 대비 소폭 개선되어 -1,130만 달러를 기록했습니다. 마케팅 및 소비자 관리 비용은 각각 26%, 33% 감소하여 비용 효율성이 향상되었습니다.
GoHealth Inc. (NASDAQ : GOCO) a annoncé des résultats difficiles pour le deuxième trimestre 2025, avec des revenus nets en baisse de 11,2 % en glissement annuel à 94,0 millions de dollars. L'entreprise a subi des baisses importantes des revenus partenaires (-44,4 %) et des revenus hors agence (-79,4 %), partiellement compensées par la croissance du segment GoHealth Protect.
La société a obtenu 115 millions de dollars de nouveaux prêts et de prêts regroupés et a modifié son accord de crédit pour suspendre les paiements de principal à court terme. Le deuxième trimestre s'est soldé par une perte nette de 115,9 millions de dollars, incluant une charge de dépréciation d'actifs incorporels de 53 millions, bien que l'EBITDA ajusté ait montré une légère amélioration à -11,3 millions en glissement annuel. L'efficacité des coûts s'est améliorée avec une baisse des dépenses marketing et service client respectivement de 26 % et 33 %.
GoHealth Inc. (NASDAQ: GOCO) meldete herausfordernde Ergebnisse für das zweite Quartal 2025, mit einem Rückgang der Nettoumsätze um 11,2% im Jahresvergleich auf 94,0 Mio. USD. Das Unternehmen verzeichnete erhebliche Rückgänge bei den Partnererlösen (-44,4%) und den Nicht-Agentur-Erlösen (-79,4%), die teilweise durch Wachstum im GoHealth Protect-Segment ausgeglichen wurden.
Das Unternehmen sicherte sich 115 Mio. USD an neuen und zusammengefassten Krediten und änderte seine Kreditvereinbarung, um kurzfristige Tilgungszahlungen auszusetzen. Das zweite Quartal endete mit einem Nettoverlust von 115,9 Mio. USD, einschließlich einer Wertminderung von immateriellen Vermögenswerten in Höhe von 53 Mio. USD, wobei das bereinigte EBITDA eine leichte Verbesserung auf -11,3 Mio. USD im Jahresvergleich zeigte. Die Kosteneffizienz verbesserte sich durch Rückgänge der Marketing- und Verbraucherkosten um 26 % bzw. 33 %.
- None.
- Net revenues declined 11.2% year-over-year to $94.0M
- Partner revenue dropped 44.4% and non-agency revenue fell 79.4%
- Reported substantial net loss of $115.9M in Q2
- $53M intangible asset impairment charge
- Total submissions declined 7.5%
Dallas, Texas--(Newsfile Corp. - August 8, 2025) - GoHealth Inc. (NASDAQ: GOCO): Stonegate Capital Partners updates their coverage on GoHealth Inc. (NASDAQ: GOCO). GoHealth, Inc. delivered a challenged second quarter in 2025, highlighted by revenue declines and contracting margins. Net revenues decreased
To view the full announcement, including downloadable images, bios, and more, click here.
Key Takeaways:
- Secured
$115M in new and rolled-up loans, amended credit agreement waiving near-term principal payments, and created$250M debt basket to pursue strategic deals. - Reported a
$115.9M net loss in Q2, impacted by a$53M intangible asset impairment charge; adjusted EBITDA improved slightly y/y to -$11.3M . - Marketing and consumer care expenses fell
26% and33% y/y, respectively, driving improved cost efficiency per submission despite a7.5% decline in total submissions.
Click image above to view full announcement.
About Stonegate
Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies.
Contacts:
Stonegate Capital Partners
(214) 987-4121
info@stonegateinc.com
Source: Stonegate, Inc.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/261805
FAQ
What were GoHealth's (GOCO) Q2 2025 financial results?
How much did GOCO's partner and non-agency revenues decline in Q2 2025?
What cost reduction measures did GoHealth (GOCO) implement in Q2 2025?
What new financing did GoHealth (GOCO) secure in Q2 2025?
How did GOCO's submission volumes perform in Q2 2025?
